Abate Kristin (CIK 0002045943)

Latest company ownership

Role: Chief Accounting Officer
Shares held
22,845
Last filed at
Oct 16, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2025Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Oct 1, 2025 Oct 3, 2025 Karyopharm Therapeutics Inc. Chief Accounting Officer Sell 47.5 -362 -3.48% $2.3K
Sep 12, 2025 Sep 16, 2025 Karyopharm Therapeutics Inc. Chief Accounting Officer Sell 60.0 +23 0.22% $147.9
Sep 3, 2025 Sep 4, 2025 Karyopharm Therapeutics Inc. Chief Accounting Officer Sell 52.5 -12 -0.13% $81.4
Jul 22, 2025 Jul 23, 2025 Karyopharm Therapeutics Inc. Chief Accounting Officer Sell 47.5 -238 -2.45% $952
Mar 4, 2025 Mar 6, 2025 Karyopharm Therapeutics Inc. Chief Accounting Officer Sell 47.5 -571 -5.55% $3.6K